NASDAQ:AYTU

AYTU Stock Slips Before Exxua Update Investors Are Watching
····

AYTU Stock Slips Before Exxua Update Investors Are Watching

Aytu BioPharma shares fell 3% to $2.08 on Thursday after reporting a quarterly revenue drop to $12.4 million from $18.5 million a year earlier. Exxua, its new antidepressant, contributed $2.4 million, while legacy ADHD drug sales declined. The company will present at the Lytham Partners Spring 2026 Investor Conference on May 28. Cash and cash equivalents stood at $26.7 million at quarter-end.
May 21, 2026

Stock Market Today

  • Asia-Pacific markets slip amid Iran-U.S. negotiation uncertainties
    May 27, 2026, 8:23 PM EDT. Asia-Pacific markets opened lower on mixed signals from Iran-U.S. talks, despite U.S. Secretary of State Marco Rubio noting progress and a diplomatic focus. Iranian state media report on restoring Strait of Hormuz commercial traffic was denied by the White House as fabrication. Crude oil futures climbed nearly 2%, with West Texas Intermediate at $90.33 and Brent crude at $96.05 per barrel. Key regional indices declined: South Korea's Kospi fell 0.29%, Japan's Nikkei 225 dropped 0.76%, and Australia's S&P/ASX 200 slipped 0.75%. Investors remain cautious amid fragile ceasefire and geopolitical risks affecting markets globally.